about
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objec...
Read More
17.14
0.63
(3.82%)
2.0M
XNAS Volume
XNAS 14 Nov, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Immunome Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..